MedPath

A CLINICAL TRIAL TO STUDY THE EFFECT OF ALENDRONATE GEL IN CLASS II FURCATION DEFECT

Phase 4
Conditions
Health Condition 1: K088- Other specified disorders of teethand supporting structures
Registration Number
CTRI/2023/07/055485
Lead Sponsor
PRAVARA INSTITUTE OF MEDICAL SCIENCES, LONI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patient between age 30 â?? 50 years of either sex

2)Patient with bilateral mandibular class II furcation defect

3)Patient ready to give informed consent

4)Patients with endodontically vital tooth

5)Depth of furcation 2-4 mm

Exclusion Criteria

1)Patient with known systemic disease

2)Patient receiving systemic Alendronate sodium

3)Patient with known allergy to alendronate sodium

4)Pregnant lactating females

5)Use of tobacco in any form

6)Patient with unilateral class II furcation

7)Patients who have taken any type of periodontal therapy prior to 6 months of initial examination

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
effectiveness of alendronate gel under clinical parameters like probing depth and clinical attachment level along with bone fill of furcation defectTimepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
effectiveness of alendronate under clinical <br/ ><br>parameters like probing depth & clinical <br/ ><br>attachment level along with bone fill of furcation <br/ ><br>defect in correlation to age & genderTimepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath